For citations:
Lisitsyna T.A., Abramkin A.A., Veltishchev D.Yu., Seravina O.F., Kovalevskaya O.B., Borisova A.B., Ignatiev V.G., Nasonov E.L. Efficacy of olokizumab against comorbid depressive disorder in patients with rheumatoid arthritis: Preliminary results of the study. Rheumatology Science and Practice. 2023;61(2):188-198. (In Russ.) https://doi.org/10.47360/1995-4484-2023-188-198